114 related articles for article (PubMed ID: 31122146)
1. MMP-10 and TIMP-1 as indicators of severe sepsis in adult hematological patients with febrile neutropenia.
Becker S; Korpelainen S; Arvonen M; Hämäläinen S; Jantunen E; Lappalainen M; Pulkki K; Riikonen P; Juutilainen A
Leuk Lymphoma; 2019 Dec; 60(12):3036-3043. PubMed ID: 31122146
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinase-9, -10, and tissue inhibitor of matrix metalloproteinases-1 blood levels as biomarkers of severity and mortality in sepsis.
Lorente L; Martín MM; Labarta L; Díaz C; Solé-Violán J; Blanquer J; Orbe J; Rodríguez JA; Jiménez A; Borreguero-León JM; Belmonte F; Medina JC; Llimiñana MC; Ferrer-Agüero JM; Ferreres J; Mora ML; Lubillo S; Sánchez M; Barrios Y; Sierra A; Páramo JA
Crit Care; 2009; 13(5):R158. PubMed ID: 19799791
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of New Diagnostic Biomarkers in Pediatric Sepsis: Matrix Metalloproteinase-9, Tissue Inhibitor of Metalloproteinase-1, Mid-Regional Pro-Atrial Natriuretic Peptide, and Adipocyte Fatty-Acid Binding Protein.
Alqahtani MF; Smith CM; Weiss SL; Dawson S; Ralay Ranaivo H; Wainwright MS
PLoS One; 2016; 11(4):e0153645. PubMed ID: 27089280
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic and prognostic value of neutrophil gelatinase-associated lipocalin, matrix metalloproteinase-9, and tissue inhibitor of matrix metalloproteinases-1 for sepsis in the Emergency Department: an observational study.
Wang M; Zhang Q; Zhao X; Dong G; Li C
Crit Care; 2014 Nov; 18(6):634. PubMed ID: 25407832
[TBL] [Abstract][Full Text] [Related]
5. Serum caspase-cleaved cytokeratin-18 fragment as a prognostic biomarker in hematological patients with febrile neutropenia.
Intke C; Korpelainen S; Lappalainen M; Vänskä M; Hämäläinen S; Pulkki K; Jantunen E; Juutilainen A; Purhonen AK
Clin Exp Med; 2022 Feb; 22(1):83-93. PubMed ID: 34255216
[TBL] [Abstract][Full Text] [Related]
6. Soluble CD14 as a Diagnostic and Prognostic Biomarker in Hematological Patients with Febrile Neutropenia.
Korpelainen S; Intke C; Hämäläinen S; Jantunen E; Juutilainen A; Pulkki K
Dis Markers; 2017; 2017():9805609. PubMed ID: 28845081
[TBL] [Abstract][Full Text] [Related]
7. Clinical features of febrile neutropenia and bloodstream infection in autologous hematopoietic cell transplantation: Comparison to those in intensive chemotherapy for acute myeloid leukemia.
Yoshino N; Kimura SI; Matsuoka A; Meno T; Ishikawa T; Nakamura Y; Kawamura M; Takeshita J; Kawamura S; Misaki Y; Yoshimura K; Gomyo A; Okada Y; Tamaki M; Akahoshi Y; Kusuda M; Kameda K; Tanihara A; Wada H; Nakasone H; Kako S; Kanda Y
J Infect Chemother; 2023 Apr; 29(4):384-390. PubMed ID: 36669687
[TBL] [Abstract][Full Text] [Related]
8. Fluoroquinolone prophylaxis reduces febrile neutropenia, bloodstream infections from mucosal translocations, and intensive care admissions in high risk hematological patients, a single center experience.
Chung SJ; Miller RA; Permpalung N; Baker AW; Diehl LF; Rizzieri DA; Alexander BD
Leuk Lymphoma; 2019 Feb; 60(2):488-492. PubMed ID: 30126315
[No Abstract] [Full Text] [Related]
9. Factors associated with severe sepsis: prospective study of 94 neutropenic febrile episodes.
Jeddi R; Achour M; Amor RB; Aissaoui L; Bouterâa W; Kacem K; Lakhal RB; Abid HB; BelHadjAli Z; Turki A; Meddeb B
Hematology; 2010 Feb; 15(1):28-32. PubMed ID: 20132659
[TBL] [Abstract][Full Text] [Related]
10. Matrix-metalloproteinases and their inhibitors are elevated in severe sepsis: prognostic value of TIMP-1 in severe sepsis.
Hoffmann U; Bertsch T; Dvortsak E; Liebetrau C; Lang S; Liebe V; Huhle G; Borggrefe M; Brueckmann M
Scand J Infect Dis; 2006; 38(10):867-72. PubMed ID: 17008230
[TBL] [Abstract][Full Text] [Related]
11. Procalcitonin as a marker of Gram-negative bloodstream infections in hematological patients with febrile neutropenia.
Luo X; Chen S; Zhang J; Ren J; Chen M; Lin K; Zhu H; Zheng R; Zheng Z; Chen Z; Hu J; Yang T
Leuk Lymphoma; 2019 Oct; 60(10):2441-2448. PubMed ID: 30806111
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic Value of Matrix Metalloproteinase-9 and Tissue Inhibitor of Matrix Metalloproteinase-1 in Sepsis-Associated Acute Kidney Injury.
Bojic S; Kotur-Stevuljevic J; Kalezic N; Stevanovic P; Jelic-Ivanovic Z; Bilanovic D; Memon L; Damnjanovic M; Kalaba Z; Simic-Ogrizovic S
Tohoku J Exp Med; 2015 Oct; 237(2):103-9. PubMed ID: 26399271
[TBL] [Abstract][Full Text] [Related]
13. Dynamic changes of matrix metalloproteinases and their tissue inhibitors in severe sepsis.
Mühl D; Nagy B; Woth G; Falusi B; Bogár L; Weber G; Lantos J
J Crit Care; 2011 Dec; 26(6):550-5. PubMed ID: 21530151
[TBL] [Abstract][Full Text] [Related]
14. Systemic matrix metalloproteinase-8 and tissue inhibitor of metalloproteinases-1 levels in severe sepsis-associated coagulopathy.
Sivula M; Hästbacka J; Kuitunen A; Lassila R; Tervahartiala T; Sorsa T; Pettilä V
Acta Anaesthesiol Scand; 2015 Feb; 59(2):176-84. PubMed ID: 25329743
[TBL] [Abstract][Full Text] [Related]
15. Serum MMP-8 and TIMP-1 in critically ill patients with acute respiratory failure: TIMP-1 is associated with increased 90-day mortality.
Hästbacka J; Linko R; Tervahartiala T; Varpula T; Hovilehto S; Parviainen I; Vaara ST; Sorsa T; Pettilä V
Anesth Analg; 2014 Apr; 118(4):790-8. PubMed ID: 24651234
[TBL] [Abstract][Full Text] [Related]
16. Direct costs associated with febrile neutropenia in inpatients with hematological diseases in Singapore.
Zhou YP; Jin J; Ding Y; Chee YL; Koh LP; Chng WJ; Chan DS; Hsu LY
Support Care Cancer; 2014 Jun; 22(6):1447-51. PubMed ID: 24287505
[TBL] [Abstract][Full Text] [Related]
17. Serum MMP-8, -9 and TIMP-1 in sepsis: high serum levels of MMP-8 and TIMP-1 are associated with fatal outcome in a multicentre, prospective cohort study. Hypothetical impact of tetracyclines.
Lauhio A; Hästbacka J; Pettilä V; Tervahartiala T; Karlsson S; Varpula T; Varpula M; Ruokonen E; Sorsa T; Kolho E
Pharmacol Res; 2011 Dec; 64(6):590-4. PubMed ID: 21742038
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of sepsis biomarkers in hematopoietic stem cell transplant recipients in a condition of high prevalence of gram-negative pathogens.
Stoma I; Karpov I; Uss A; Rummo O; Milanovich N; Iskrov I
Hematol Oncol Stem Cell Ther; 2017 Mar; 10(1):15-21. PubMed ID: 27793578
[TBL] [Abstract][Full Text] [Related]
19. Asymmetric dimethylarginine in the assessment of febrile neutropenia in hematological patients.
Lappalainen M; Hämäläinen S; Juutilainen A; Koivula I; Pulkki K; Jantunen E
Scand J Clin Lab Invest; 2017 Apr; 77(2):130-134. PubMed ID: 28218011
[TBL] [Abstract][Full Text] [Related]
20. Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the EURODIAB Prospective Complications Study.
Peeters SA; Engelen L; Buijs J; Chaturvedi N; Fuller JH; Schalkwijk CG; Stehouwer CD;
Cardiovasc Diabetol; 2015 Mar; 14():31. PubMed ID: 25848912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]